Autographa californica nucleopolyhedrovirus Ac16 is 1 of 17 genes conserved within Type 1 nucleopolyhedroviruses. This report demonstrates that multiple isoforms of the protein encoded by Ac16, BV/ODV-E26 (E26), are present in the infected cell. One form of E26 associates with viral DNA or DNA-binding proteins, while a second form associates with intracellular membranes and this is likely due to palmitoylation. The different forms of E26 present unique epitopes that can be discriminated by antiserum produced to bacterially or virally produced antigen. A summation of the data now available on E26 suggests that it is a multifunctional protein and the functional states assume unique conformations that can be discriminated by differing antisera.
Introduction
Knowledge of Autographa californica nucleopolyhedrovirus (AcMNPV) orf 16 (Ac16) and its encoded protein includes contradictory observations. There is general agreement that Ac16 is an early gene and that transcripts accumulate rapidly after infection. It was initially shown that Ac16 functioned in conjunction with another early gene, da41, to stimulate late gene expression (Guarino and Summers, 1988) . However, this observation was questioned when subsequent study revealed that disrupting Ac16 did not delay the expression of other late genes (O'Reilly et al., 1990) . Based upon virus replication assays performed in vitro and in insect larvae, O'Reilly et al. (1990) suggested that Ac16 is non-essential, however this was questioned when repeated attempts failed to isolate a null mutant of the Bombyx mori homolog Bm8 (Imai et al., 2004; Kang et al., 2005) . Beniya et al. (1998) reported that Ac16 encoded a structural protein that is present in the envelopes of budded and occlusion-derived virus (BV and ODV, respectively) and named the gene product BV/ODV-E26 (E26). However, Imai et al. (2004) did not detect Bm8 as a structural protein in progeny virions, rather they showed that Bm8 encoded a protein that accumulated in nuclear foci, co-localized with IE1 and bound DNA.
The confusing results of these studies suggest several possibilities: (i) even though the proteins encoded by the homologous genes Ac16 and Bm8 (E26 and Bm8, respectively) share 96% amino acid sequence identity, each functions in a different capacity during infection by AcMNPV or BmNPV; (ii) some aspects of previous studies and conclusions drawn of the functional or structural roles of E26 or Bm8 are incorrect; or (iii) E26 and Bm8 are multifunctional proteins and studies using similar but different detection tools have unknowingly detected different functional states. The goal of this study was to extend our knowledge of the AcMNPV protein E26 and to resolve some of the apparent discrepancies reported for the structure and function of E26.
We show here that multiple isoforms of E26 are present in the infected cell and the different isoforms present uniquely
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different epitopes that are discriminated by antiserum produced to bacterially or virally produced antigen. One form of E26 associates with viral DNA or DNA-binding proteins, while a second form associates with intracellular membranes. E26 membrane association is likely mediated via palmitoylation.
Results

Ac16 is predominantly early but is also a late gene
While there is general agreement that Ac16 is expressed early (Guarino and Summers, 1988; O'Reilly et al., 1990) , it has been suggested that transcripts for Ac16 are also present much later in the temporal sequence of infection. To confirm this, primer extension assays were performed early and late during infection. Like previous results, transcripts initiating at − 38 nt were detected by 2 h p.i., increased in quantity between 6 and 18 h p.i. and were still present in decreased quantity through 72 h p.i. (Fig. 1A) . Transcripts initiating near an upstream CAGT sequence (− 260 nt) were detected at maximal levels at 12 h p.i. (Fig. 1B) . Two transcripts initiating from TAAG sequences were detected at positions −783 and − 838. One of these transcripts (− 838 nt) was detected as early as 6 h p.i., while the second transcript (− 783 nt) was at maximal levels at 48 h p.i. (Fig. 1C) . Both of the − 783 and − 838 transcripts initiate within the Ac15 gene, yet the only ATG start codon associated with an open reading frame of any length is that of Ac16.
These data show that transcripts corresponding to Ac16 are abundant between 6 and 12 h p.i. However, transcripts are also present late in infection (− 38, − 260, − 783 and −838) . Thus, it is likely that E26 is synthesized both early and late during infection.
Multiple isoforms of E26 are produced during infection
Antibodies are powerful and routine tools used for protein detection. However, antibodies are themselves biological reagents and their production is based upon a biological response to dominant epitope presentation. With monoclonal antibodies, it is common to generate antibodies that distinguish between modified versions of the same protein. It is less common to observe polyclonal antisera which detect unique protein states, however if altered conformation results in presentation of different dominant antigens, then polyclonal antiserum may indeed distinguish between unique isoforms of the same protein.
Published conclusions of E26 structure and function are largely based upon antibody-generated results. One notable difference in the production of these antisera is the source of the Ac16 or Bm8 encoded protein antigen: BmNPV Bm8 was amplified and purified from bacteria (Imai et al., 2004) , whereas AcMNPV E26 was amplified and purified from baculovirus infected cells (Beniya et al., 1998) . If Bm8 or E26 present different dominant epitopes when produced in bacteria compared to virus infection, and these dominant epitopes reflect various functional states of the protein, then conclusions based upon such selected antibody detection could explain the conflicting conclusions reported for structure and function of E26. We explored this possibility using several approaches: Fig. 1 . Primer extension analyses. Four transcripts were identified using primer extension assays. These were detected at −38 (A), − 260 (B) and − 783 and − 836 (C). The placement of each of these transcripts relative to the DNA sequence and the methionine start codon of E26 is depicted in (D). The placement of the oligonucleotides used for the analyses is highlighted in gray.
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(i) generating comparable antiserum to E26 using antigen prepared by bacterial expression; (ii) removing the complexity of antiserum altogether by tagging the E26 protein with a unique antibody epitope; and (iii) comparing the profiles of expression using the various antisera.
When AcMNPV-infected cell lysates were probed with the Bm8 antibody (antigen expressed in bacteria), a unique immunoreactive band at a molecular mass of 33 kDa was detected ( Fig. 2A; lanes 4 and 5) . When the lysates were probed with an equivalent E26 antibody (antibody #12500), a similar immunoreactive protein was detected ( Fig. 2A, lanes 7 and 8) . Thus, consistent results were obtained when comparable antisera were used to probe infected cell extracts.
To remove the potential complexity of data imposed as a result of using different E26 polyclonal antisera and to test if virus infection modifies E26, Ac16 was fused with a sequence encoding the amino acids comprising the T7 epitope (E26-T7; T7 epitope adds 1 kDa of mass) and T7 antibody was used for detection. When E26-T7 was transiently expressed in Sf9 cells, a single immunoreactive band migrating at approximately 35 kDa was detected (Fig. 1A, lane 9) . If, however, cells transiently expressing E26-T7 were then infected with AcMNPV, two proteins were detected; one of these is of a molecular mass similar to that detected with both Bm8 and E26 antiserum #12,500 (33 kDa), while the second protein is at a molecular mass of 26 kDa ( Fig. 2A, lane 10) . This result could be due to several factors: (i) events occurring during virus infection are uniquely modifying E26 in ways that affect its migration pattern using SDS-PAGE; or (ii) the smaller forms of E26 are the result of protein degradation.
If virus infection is producing modified forms of E26, it is possible that the #7554 antiserum (generated to E26 purified from infected cells) recognizes epitopes that are exposed as a result of viral modification. When AcMNPV-infected cell lysates were probed with #7554 antibody, the first immunoreactive protein detected (6 h p.i.) had a molecular mass of 26 kDa, similar to one of the AcMNPV-modified forms of E26-T7 ( Fig. 2B ; compare lane 10 with lanes 12 and 13). With increased exposure of the gel, it is clear that by 24 h p.i. (compare lanes 13 and 14) immunoreactive bands with both smaller and larger masses were also present in the infected cell lysate and these include the 33 kDa form detected by Bm8 and #12500 antisera (lanes 14 and 15). Considering that the 26 kDa form of E26 was the first form detected during infection, and it was present in the highest quantity throughout infection, we consider it unlikely that it is the product of protein degradation.
Previous work has shown that, when E26 is produced under the control of the polyhedrin promoter (E26 polh ), thus in higher Fig. 2 . E26 is modified during viral infection to 33 and 26 kDa isoforms. (A) Infected cell lysates were probed with two antisera produced to bacterially produced E26 antigen. The time post infection is noted above the gel. Lanes 3-5 were probed with antiserum produced to BmNPV Bm8 while lanes 6-8 were probed with AcMNPV E26. Lanes 9-10 show that, when produced in the absence of other viral protein (transient expression, (T)), E26 migrates at 35 kDa. If the cells are then infected (T/E2), E26 migrates at 33 and 26 kDa. Lanes 9 and 10 were not loaded at equivalent protein concentration, the important point of these data is the mass shifts of E26 that result from infection. We also note that, while the cells were collected at 48 h p.i., visible hallmarks of AcMNPV infection (occlusion production) suggest that infection was delayed and more likely represents a time point closer to 28-36 h p.i. (B) Cell lysates from AcMNPV-infected cells probed with antibody generated to virally produced E26 recognize the 26 kDa isoform of E26 (lanes 11-13; time post infection is noted above the gel). Lanes 14-15 show an increased exposure of the same Western blot showing that the 33 kDa isoform is present and recognized by the #7554 antiserum. Other forms of E26 with smaller molecular masses are also present. (C) E26-T7 polh recombinant virus was used to infect Sf9 cells (time post infection is noted above the gel) and cell lysates were analyzed using T7 antibody. The lane noted as T (lane 17) represents an extract of Sf9 cells transiently expressing E26-T7 for reference. Considering that molecular weight markers can vary substantially, especially in the regions of lower molecular weights, both Unstained Low Molecular Weight Markers (lane 1) and Pre-stained Precision Plus Blue Markers (lane 2; both obtained from Promega) are shown for reference. The M r assignments for the isoforms of E26 were determined using the unstained standards.
quantity and later in the temporal sequence compared to wild type, E26 accumulates within the virogenic stroma (Beniya et al., 1998) . To determine if E26 produced under the control of the polyhedrin promoter undergoes an apparent mass shift like that observed during wild type infection (Fig. 2B, lanes 12-15) , cell lysates collected from a temporal course of infection by E26-T7 polh were probed with the T7 antibody. As expected, polyhedrin-expressed E26-T7 was not detected early (6 h p.i., lane 18), but at 18 h p.i. E26-T7 was detected at a molecular mass of 33 kDa. The smaller, 26 kDa form of E26 that is readily detected in wild type AcMNPV-infected cells was not detected until very late in infection, and even then only in small quantity (lane 22). For reference, a sample of lysate prepared from Sf9 cells transiently expressing E26-T7 was included in the analysis (Fig. 2C , lane 17 and lane 9 are comparable samples). These results suggest that the temporal sequence of production and/or quantity of E26 are somehow important for the modification(s) of E26 that results in the mass shift to 26 kDa observed in wild type infected cells.
These data show that antiserum generated to protein produced in bacteria or virus-infected cells demonstrates a marked difference in their ability to recognize the various forms of E26. Antibodies generated to bacterially produced antigen detect the higher molecular mass (33-kDa) form, whereas antibodies produced to virally produced antigen have a high affinity for the smaller, 26 kDa form.
We note that various molecular weight standards used for SDS-PAGE generate different predictions of protein mass, and this is shown in Fig. 2A . Lane 1 shows the migration pattern of unstained standards, while lane 2 shows the corresponding migration pattern of pre-stained standards (Biorad Low Range and Precision Plus Blue, respectively). Throughout this study, the apparent molecular weights were determined using the unstained standards. Since molecular mass determination using SDS-PAGE is a relative assignment, the molecular mass assignment is less important than the relative shifts in molecular mass detected for the various isoforms of E26.
E26 is palmitoylated and associates with membranes
It has been shown that E26 associates with membranes in infected Sf9 cells Saksena et al., 2004) , however previous results also suggest that E26 is not an integral membrane protein (Beniya et al., 1998) . Our continuing experiments show that varying amounts of E26 fractionate into detergent and aqueous phases depending upon the type and concentration of detergent used for analyses (unpublished data). When 1% Triton X-114 was used to extract infected cell lysates, the 26 kDa form of E26 was detected only in the detergent phase ( Fig. 3A; lanes 3-10) . Thus, these conditions were used for the comparative analysis described in the next section.
Analysis of highly expressed E26 using the recombinant viruses E26 polh and E26-T7 polh suggests that timing and quantity of E26 produced during infection are not only important for modification of E26 to the 26 kDa form but also for localization in the cell (Fig. 2 and Beniya et al., 1998) . To identify if these alterations affect E26 membrane affinity, lysates of E26-T7 polh infected cells were extracted with Triton X-114. As expected by data shown in Fig. 2C , the dominant form of E26 produced in cells infected with E26-T7 polh was the 33 kDa isoform. A large amount of E26-T7 was detected in the insoluble fraction and aqueous phase ( Fig. 3A; lane 12 and 14) , while a smaller quantity fractionated into the detergent phase (lane 13). Thus, in contrast to the results observed with E26 during wild type infection, when expressed in high quantity, a substantial portion of E26 does not associate with membranes. These results are consistent with immuno-electron microscopy observations obtained with E26 polh infected cells that show that, in addition to its normal localization in intranuclear microvesicles and ODV envelope, large quantities of E26 accumulate in the DNA-rich virogenic stroma (Beniya et al., 1998) .
To evaluate if infection is required for the membrane association of E26, Sf9 cells transiently expressing E26-T7 were fractionated using Triton X-114. In these uninfected cells, E26-T7 was only detected in the insoluble and aqueous fractions (Fig. 3A , lanes 16 and 18) and was not observed in the detergent fraction (lane 17). This strongly suggests that viral infection is required to confer E26 with membrane association properties.
Considering that E26 associates with the viral envelope protein ODV-E66 , it is possible that E26 does not itself have an affinity for membranes, rather its membrane association is mediated by interactions with other viral proteins. To test this, radiolabeled E26 was translated in vitro in the presence of microsomes prepared from uninfected or AcMNPV-infected Sf9 cells. When translated in the presence of Sf9-derived microsomes, E26 remained in the soluble fraction and only a trace amount was detected in the microsomal membrane pellet ( Fig. 3B; lanes 1-3) . A similar result was obtained when E26 was translated in the presence of microsomes derived from AcMNPV-infected cells (lanes 4-6). We conclude from these results that E26 membrane affinity is not due to its interaction with other cellular or viral membrane proteins.
Lipid anchored proteins frequently fractionate into both aqueous and detergent phases depending upon the detergent tested and stringency of experimental conditions. This is the type of variability in results observed with E26 using various detergent fractionation protocols (compare results obtained here with previous results of Beniya et al., 1998 ). An analysis of the amino acid sequence using the palmitoylation-predictor program CSS-PALM (Zhou et al., 2006 ) reveals three cysteines that have an increased probability to serve as palmitoylation substrates ( Fig. 4; ★) . To determine if E26 was palmitoylated, cells were infected with AcMNPV, starved, supplemented with 3 [H]-palmitate and precipitated using #7554 antibody (the positive control gp64 was precipitated using mAb AcV1). The result shows that E26 was labeled with 3 [H]-palmitate ( Fig. 3C ; lane 2) and the palmitoylated protein migrated at an apparent molecular mass of 26 kDa.
We conclude that, under conditions of wild type infection, the 26 kDa isoform of E26 has a high affinity for membranes and this form is palmitoylated. However, the mass shift to 26 kDa is not a requirement for membrane association, the A u t h o r ' s p e r s o n a l c o p y 33 kDa isoform produced during infection with E26-T7 polh also demonstrates some, albeit limited, membrane affinity.
Deletion of domains within E26 alters its intracellular localization
To identify domains within E26 essential for membrane association and targeting to intranuclear membranes and ODV envelope, two mutation constructs of E26 were generated. One of these had the N-terminal 70 amino acids deleted (E26 71-225 ), while the second had the C-terminal 77 amino acids deleted (E26 1-148 ). Both mutants include the putative coiled-coil domain (Fig. 4, underline) , the basic region that also comprises a predicted nuclear localization sequence (NLS; Fig. 4, yellow) , a putative amphipathic helix (Fig. 4, red dash) and an in-frame C-terminal fusion of the amino acids comprising the epitope for T7 antibody (Fig. 5A) . For these experiments, we note that the T7 antibody will only detect the truncated mutant protein, however the E26 antibody #7554 should detect both mutant and native E26.
The first approach was to transiently express each E26 construct in Sf9 cells, allow the cells to recover, infect with 1-3) or AcMNPV-infected cell derived microsomes (lanes 4-8). After translation, the sample was separated into the membrane pellet and soluble fraction, separated using SDS-PAGE and radiolabeled E26 visualized using autoradiography. The notations used are: T = total translation mixture; S = soluble fraction; M = membrane pellet. (C) Infected cells were starved, supplemented with 3 H-palmitate for 8 h and then precipitated using either preimmune antiserum (PI; lane 1), #7554 serum (E26; lane 2) or mAb AcV1 (gp64). The precipitated sample was separated using SDS-PAGE, dried and labeled proteins visualized using autoradiography.
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AcMNPV and then analyze the cells using immuno-confocal microscopy. When the E26 71-225 mutant protein was tested, antibodies #7554 and T7 detected proteins with significant colocalization (Fig. 5B) . Both antibodies detected proteins that accumulated at the nuclear rim, within intranuclear foci and the virogenic stroma. This result is in sharp contrast with that obtained with E26 1-148 . Deletion of the C-terminus of E26 resulted in the truncated protein locating predominantly to the infected cell virogenic stroma (T7 antibody). Antibody #7554 detected wild type E26 in intranuclear foci of membrane microvesicles with only marginal detection of the T7 fusion in the virogenic stroma (Fig. 5B) . Deletion of the C-terminal 77 amino acids appears to not only direct the truncated protein to DNA-rich regions within the infected cell nucleus, with little or no protein being directed to intranuclear membranes, but also result in a protein conformation that is no longer recognized by antibody #7554. The localization of E26 1-148 was similar to that observed when analyzing the E26-βgal fusion protein produced in the recombinant virus vDa26z (O'Reilly et al., 1990) . In this virus, the first 118 amino acids are fused to β-galactosidase (noted in Fig. 4) . Thus, like E26 1-148 , the C-terminal region of E26 is deleted in the E26-βgal protein. E26-βgal localized exclusively within the virogenic stroma in infected cells (Fig. 5C) .
Previous results showed that when E26 was transiently expressed (i.e. in the absence of other viral proteins) it was not modified to lower molecular weight forms and it did not readily associate with membranes. It was not a surprise then to observe that transiently expressed E26 was detected exclusively within the nucleus (Fig. 5D ).
The localization of E26 is altered during the temporal sequence of AcMNPV infection
During AcMNPV infection, the location of E26 changes in a reproducible, but temporally regulated fashion. Early in infection (1-6 h p.i.), E26 was detected in punctate foci both in the cytoplasm and nucleus (Fig. 5E ). Previous analysis using immuno-electron microscopy has shown that these foci represent both electron dense, chromatin-like regions and membrane vesicles (Beniya et al., 1998) . At approximately 8-12 h p.i., E26 localized in a more generalized pattern within DNA-rich regions in the nucleus, and a number of the observations included E26 accumulating in intranuclear foci (Fig. 5E ). This pattern of localization resembles that previously reported for Bm8 in cells infected with BmNPV (Imai et al., 2004) . At approximately 16 h p.i., the dominant localization pattern of E26 changed again; E26 was now detected in smaller quantity within the DNA-rich regions of the virogenic stroma and increased immunofluorescence now associated with cytoplasmic and nuclear membranes, along with foci of viralinduced intranuclear membrane microvesicles (Fig. 5E and Beniya et al., 1998) . By 18 h p.i., E26 located almost exclusively in foci of viral-induced microvesicles within the nucleus (Fig. 5E) , and this pattern remained constant throughout infection. These temporally regulated differences in protein Fig. 4 . Amino acid sequences of E26 from various Type 1 NPVs. The nucleopolyhedroviruses listed in the lineup are: AcNPV-Autographa californica; RoNPVRachiplusia ou; BmNPV-Bombyx mori; EpNPV-Epiphyas postvittana; OpNPV-Orgyia pseudotsugata; ApNPV-Antheraea peryni; CfNPV-Choristoneura fumiferana; HcNPV-Hyphantria cunea. Various structural features of the E26 proteins are noted: the basic region that includes a nuclear localization-like sequence is highlighted in yellow, a putative coiled-coil region is underlined and putative amphipathic helix is noted above the sequence with a red dashed line. Identical amino acids are highlighted in dark gray, similar amino acids are highlighted with light gray. Highly conserved cysteines are highlighted in red, and the three cysteines that are predicted to serve as substrates for palmitate are noted above the sequence with an asterisk. Fig. 5 . Immuno-confocal microscopy analyses of E26 and E26 derivatives. (A) Notable motifs within E26 are noted, NLS = nuclear localization sequence; C = cysteines predicted to serve as substrates for palmitate modification. E26 71-225 is a derivative that has the N-terminal 70 amino acids deleted and E26 1-148 has the C-terminal 77 amino acids deleted. Both truncation derivatives are fused at the C-terminus with the amino acids comprising the epitope for T7 antibody. (B) Cells transiently expressing each derivative were infected with AcMNPV and then analyzed using immuno-confocal microscopy. The truncation derivative of E26-T7 was detected using the T7 antibody, whereas native E26 was detected using #7554 antiserum. The substantial co-localization pattern of T7 and #7554 antibody (merge) shows that the E26 71-225 derivative is recognized by both of these antisera, whereas #7554 antiserum did not recognize the E26 1-148 derivative. Location of the nucleus and DNA-rich regions was detected using DAPI stain. We note that while the cells were collected at 48 h p.i. visible hallmarks of AcMNPV infection (occlusion production) suggest that infection was delayed, and a visual overview of the cell population suggests that infection represents a time point closer to 28-36 h p.i. The delay and lack of viral occlusions are shown in the bright field image. (C) A 48 h p.i. sample of cells infected with the mutant virus vDa26z was analyzed using antibody to β-galactosidase. (D) Sf9 cells transiently expressing E26 were analyzed using #7554 antibody. The antibody to insect lamin Dm0 (Adl67) was used to note the nuclear periphery. (E) Sf9 cells were infected with AcMNPV and then analyzed at various times post infection. Antibody #7554 was used to detect E26 and DAPI was used to identify the nucleus and DNA-rich regions.
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targeting likely reflect different functional states of E26 and are consistent with the idea that E26 performs multiple activities throughout the temporal sequence of infection.
Discussion
Currently, the role and function of Ac16 and its encoded protein, E26, are an enigma. The Ac16 gene is only present in about half of the sequenced and annotated baculoviruses and one would expect that such a poorly conserved gene could easily be deleted from the genome. However, Ac16 is 1 of the 17 genes conserved within the genomes of Type 1 NPVs (Herniou et al., 2003) . Repeated attempts by ourselves and others have failed to generate an Ac16-null virus. These observations strongly suggest that, within the Group 1 NPVs, Ac16 provides an essential function.
E26 is targeted to different locations within the infected cell in a temporally regulated fashion. We speculate that the targeting of E26 is controlled through regulated protein modification events, and our observations show that these modification(s) alter apparent molecular mass, properties of membrane association and protein destination. In the absence of other viral proteins, E26 has an apparent molecular mass of 35 kDa, is soluble, locates in the cell nucleus and has an affinity for DNA-rich regions. In contrast, during AcMNPV infection, at least two forms of E26 are present and these are uniquely recognized by various antibody preparations. One form migrates at 26 kDa, is palmitoylated and readily associates with cellular membranes. This form is predominantly recognized by antiserum #7554, which was generated to E26 purified from infected cells. A second form of E26 migrates at 33 kDa and this form is recognized by antiserum generated to bacterially produced E26 (Bm8 and #12500). Considering that these antisera only detect E26 associated with the cell nucleus and co-localizing with IE1 (Imai et al., 2004 ), it appears that this isoform has the greater affinity for DNA or DNAbinding proteins.
Many of the previous and current conclusions about E26 are based upon results generated using antibody probes. The data presented here strongly suggest that the specificity of the antibody preparations varies depending upon the source of E26 antigen. We now know that E26 is modified during infection, and it is not unrealistic to conclude that modification(s) that result in such substantial alterations of biological properties would also alter immunogenic epitope presentations.
E26 binds to IE1 and this activity is essential
While there remains an incomplete understanding of the molecular events that confer unique properties to E26, certain cohesive elements of E26 structure and function are emerging. Current data strongly suggest that the N-terminal region of E26 provides an essential function and contains the binding site for IE1 (Kang et al., 2005) . One early study suggested that Ac16 could easily be mutated, however we now understand that the essential N-terminal domain was retained within the genome of this recombinant virus. Indeed, this domain has been retained in both reported E26 mutant viruses: vDa26z and BmD8 (O'Reilly et al., 1990; Imai et al., 2004) . Since these viruses appear to retain the essential activity of E26, then the early observation that E26 functions to regulate late gene expression may still be valid. E26 may function in an essential role during viral DNA replication of Group 1 NPVs.
When E26 is transiently expressed in Sf9 cells (absence of other viral proteins), it accumulates within the nucleus (Fig. 5D ) and fractionates in the aqueous and insoluble, DNA-rich fraction. These data suggest that one important function of E26 is performed in relationship with DNA and this function occurs in the absence of other viral proteins. Considering that the antisera generated to bacterially produced E26 appear to preferentially recognize the DNA-binding, soluble form of E26, we conclude that this form does not require viral modification to be active.
E26 has a second functional activity that is associated with membranes
Previously published data clearly show that E26 associates with ER membranes and that it associates with the viral inner nuclear membrane sorting motif (INM-SM) derived from ODV-E66 . The data presented here are consistent with a membrane-associated function of E26 and clearly suggest that infection is responsible for post-translational events that support its membrane association. By 24 h p.i., a substantial amount of E26 fractionates with the detergent Triton X-114. One explanation for this affinity may be the posttranslational covalent linkage with palmitate. Biochemically, palmitoylation enhances the surface hydrophobicity of protein substrates and promotes their interactions with membranes (Kleuss and Krause, 2003) . Palmitoylation is a reversible lipid modification (Linder and Deschenes, 2003; Dietrich and Ungermann, 2004 ) that can regulate intracellular trafficking and sorting Schneider et al., 2005) , subcellular localization (Van Itallie et al., 2005) and functional activity (Sudo et al., 1992) . As such, palmitoylation alone could explain the dynamic alterations of E26 that result in apparent molecular mass shifts, membrane association properties or different subcellular localizations.
Predicting cysteine substrates for palmitoylation is a process that is not well defined. The common denominator for most palmitoylated cysteines is the presence of a membrane targeting sequence that consists of positive charges, adjacent lipid anchors or transmembrane domains (Dietrich and Ungermann, 2004) . Programs designed to predict cysteine substrates that have a high likelihood of serving as palmitate substrates are emerging, and one such program, CSS-PALM (Zhou et al., 2006) , predicts three cysteines within E26 that have an increased probability of serving as substrate for palmitoylation. The cysteine at position 128 scores the highest in this analysis ( Fig. 4; red star) . When E26 mutants are analyzed, the mutant containing an N-terminal truncation (E26 71-225 ) retains these cysteines and results show that it is still targeted to membranes, although an increased amount of E26 protein is also targeted to DNA-rich regions (Fig. 5B) . However, when two (E26 1-148 ) , the mutant E26 protein is now only detected in DNA-rich regions (Fig. 5B) . This result is consistent with the idea that one of these three cysteines serves as the substrate for the covalent linkage of palmitate. If palmitoylation results in altering the conformation of E26, then this could also explain some of the properties of the various antibodies. Antiserum generated to viral-derived antigen (#7554) only demonstrates a limited ability to recognize E26 derivatives that lack the C-terminal portion of the protein (Fig. 5B, E26 1-148 ), however it recognizes both the 26 and 33 kDa isoform of the mature protein. Antiserum generated to bacterially produced antigen (non-palmitoylated source) does not recognize the 26 kDa, membrane-associated form of E26. An understanding of the characteristics of these antibodies provides substantial insight into understanding the complexity and seemingly contradictory observations of the structure and function of E26.
A summary of the data suggests that E26 fulfills specific needs of Group 1 NPVs in three important viral activities: (i) to optimize viral DNA replication by binding to DNA and DNAbinding proteins; (ii) enhance late gene transcription in association with Ac15; and (iii) facilitate the trafficking of ODV envelope proteins from their site of insertion in the ER toward the nuclear envelope and virus induced intranuclear membranes Saksena et al., 2004 Saksena et al., , 2006 . We conclude from these studies that E26 is a multifunctional protein that assumes more than one functional conformation within the infected cell. In order to develop a comprehensive understanding of E26, additional studies directed toward understanding each of these functional activities will be required.
Materials and methods
Cell culture, recombinant virus and transient expression Spodoptera frugiperda (Sf9) cells were cultured as described in Summers and Smith (1987) . A. californica nucleopolyhedrovirus (E2 strain) was used at a multiplicity of infection of 20. Recombinant virus was generated using the technique described in Summers and Smith (1987) and PCR was used to confirm legitimate recombination in the polyhedrin gene locus. To express the genes under the control of the IE1 promoter for transient expression, constructs were cloned into the plasmid pIE1-4 (Novagen). Plasmid DNA was transfected into Sf9 cells using the calcium phosphate method described in Summers and Smith (1987) . After transfection, cells were allowed to recover for 48 h. At this time, cells were either prepared for microscopy or infected with virus.
Antibody production
Production of the E26 antiserum #7554 was described in Beniya et al. (1998) . Before use, this serum was preadsorbed with agarose-bound GST-E25 and GST-FP25K. After adsorption, no cross-reactivity to these or other viral proteins was detected. For Western blot analysis, preadsorbed #7554 serum was used at a dilution of 1:20,000. Antiserum #12500 was produced to a pMAL-E26 fusion protein. BL21 cells were transformed with the pMal-E26 fusion plasmid, induced with IPTG and mal-E26 was purified using maltose resin. Rabbits were injected with antigen 4 times at 28-day intervals, and serum was collected 14 days after the last injection. To remove cross-reactivity to cellular proteins, Sf9 cells were sequentially fixed in 3.7% paraformaldehyde and methanol, permeabilized with 0.5% Triton X-100 and washed. The serum preparation was diluted 500-fold in blocking solution (PBS, pH 7.2, 1% normal chicken serum) and incubated with the fixed, permeabilized cells for 1 h. The supernatant was collected and residual cell debris removed by centrifugation. Cross-reaction with cellular proteins was removed using this treatment, and serum was used at 1:1000 in Western blot analysis. T7 antibody (Novagen) was used at a 1:10,000 dilution. The Bm8 antiserum was kindly provided by I. Imai and used at a dilution of 1:1000.
Palmitoylation assay
The technique of Zhang et al. (2003) was used to label infected cells with 3 [H]-palmitate. Briefly, Sf9 cells were infected with AcMNPV and, at 34 h p.i., the cells were transferred from complete media to Grace's media (minus fetal bovine serum) for 1.5 h. Cells were returned to complete media and incubated with 3 [H]-palmitate (500 μCi) for 8 h. Cells were then collected, lysed and incubated with antiserum #7554, preimmune serum or mAb AcV1. The antibody bound protein was enriched using Protein A/G agarose, proteins were separated using SDS-PAGE, gel was dried and labeled proteins visualized using autoradiography.
Primer extension
Transcripts were mapped using strand-specific oligonucleotides and standard primer extension techniques using Superscript II (Sambrook et al., 1989) . Transcript initiation sites were identified by running the primer extension product concurrent with a DNA sequence reaction using the same oligonucleotide primer on the denaturing gel routinely used for DNA sequencing reactions.
Immuno-confocal microscopy
Cells were processed for light microscopy using procedures described in Braunagel et al. (1999) . Briefly, cells were collected, fixed with 3.7% paraformaldehyde and followed by methanol fixation (10 min each). Cells were treated with 0.5% Triton X-100 and rinsed with PBS. Cells were blocked with 1% normal goat or chicken serum and 3% BSA. Primary antibody was incubated overnight (4°C), washed and then incubated with secondary antibody for 1 h (room temp). When DAPI (4′-6-diamidino-2-phenylindole; 0.1 μg/ml) was used, cells were treated with DAPI for 5 s and washed. The antibodies and concentrations used were: lamin (Stuurman et al., 1995; 1:250) , E26 #7554 (1:1000), T7 antibody (Novagen; 1:1000)
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and β-galactosidase antibody (Sigma; 1:1000). Cells were viewed and photographed with a Zeiss Axiovert 135 microscope with a CARV confocal module. Images were collected at 0.75-μm intervals using Zeiss AXIOVISION 3.1 software.
Detergent fractionation
Treatment with Triton X-114 (1%) was performed using the method of Bordier (1981) . As a control, the separated samples were tested for the fractionation profiles of marker proteins: the detergent phase contained the envelope proteins ODV-E66 and ODV-E25 while p39 and FP25K fractionated into the aqueous phase.
